PGD2 DP1 receptor protects brain from ischemia-reperfusion injury

European Journal of Neuroscience

Volumn 26, Issue 1, 2007, Pages 73-78

  Saleem, Sofiyan ^a   Zhuang, Hean ^a   De Brum Fernandes, Artur J ^b   Maruyama, Takayuki ^c   Narumiya, Shuh ^d   Doré, Sylvain ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c ONO PHARMACEUTICAL CO   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

BW245C; Focal ischemia; Mouse; Neuroprotection; Prostaglandins; Stroke

Indexed keywords

5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; DP1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; PROSTAGLANDIN D2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN NERVE CELL; BRAIN PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; EXCITOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPERFUSION INJURY; STATISTICAL ANALYSIS; WILD TYPE;

ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; BODY TEMPERATURE; CELLS, CULTURED; GLUTAMIC ACID; HYDANTOINS; HYPOXIA-ISCHEMIA, BRAIN; INFARCTION, MIDDLE CEREBRAL ARTERY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN;

EID: 34447117023     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05627.x     Document Type: Article

References (44)

1. Abdel-Halim, M.S., Hamberg, M., Sjoquist, B. Anggard, E. (1977) Identification of prostaglandin D2 as a major prostaglandin in homogenates of rat brain. Prostaglandins, 14, 633 643.
2. Ahmad, A.S., Ahmad, M., de Brum-Fernandes, A.J. Doré, S. (2005) Prostaglandin EP4 receptor agonist protects against acute neurotoxicity. Brain Res., 1066, 71 77.
3. Ahmad, A.S., Saleem, S., Ahmad, M. Doré, S. (2006a) Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol. Sci., 89, 265 270.
4. Ahmad, M., Saleem, S., Zhuang, H., Ahmad, A.S., Echeverria, V., Sapirstein, A. Doré, S. (2006b) 1-HydroxyPGE1 reduces infarction volume in mouse transient cerebral ischemia. Eur. J. Neurosci., 23, 35 42.
5. Akarsu, E.S., Keskil, S., Kaymaz, M., Uysal, S., Ceviker, N., Ataoglu, O. Baykaner, K. (1998) Antiischemic effect of ZK-118.182 in rabbits: a comparative study with iloprost. Meth. Find. Exp. Clin. Pharmacol., 20, 339 342.
6. Aritake, K., Kado, Y., Inoue, T., Miyano, M. Urade, Y. (2006) Structural and functional characterization of HQL-79, an orally active, selective inhibitor for human hematopoietic prostaglandin D synthase. J. Biol. Chem., 281, 15277 15286.
7. Bazan, N.G. (2005) Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol. Neurobiol., 32, 89 103.
8. Boie, Y., Sawyer, N., Slipetz, D.M., Metters, K.M. Abramovitz, M. (1995) Molecular cloning and characterization of the human prostanoid DP receptor. J. Biol. Chem., 270, 18910 18916.
9. Chamorro, A. Hallenbeck, J. (2006) The harms and benefits of inflammatory and immune responses in vascular disease. Stroke, 37, 291 293.
10. Chen, C. Bazan, N.G. (2005) Lipid signaling: sleep, synaptic plasticity, and neuroprotection. Prostaglandins Other Lipid Mediat., 77, 65 76.
11. Coyle, J.T. Puttfarcken, P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science, 262, 689 695.
12. Crider, J.Y., Griffin, B.W. Sharif, N.A. (1999) Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists. Br. J. Pharmacol., 127, 204 210.
13. Dirnagl, U., Iadecola, C. Moskowitz, M.A. (1999) Pathobiology of ischaemic stroke: an integrated view. TINS, 22, 391 397.
14. Doré, S., Otsuka, T., Mito, T., Sugo, N., Hand, T., Wu, L., Hurn, P.D., Traystman, R.J. Andreasson, K. (2003) Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann. Neurol., 54, 155 162.
15. Doré, S., Takahashi, M., Ferris, C.D., Hester, L.D., Guastella, D. Snyder, S.H. (1999) Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl Acad. Sci. USA, 96, 2445 2450.
16. Echeverria, V., Clerman, A. Doré, S. (2005) Stimulation of PGE2 receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following β-amyloid exposure. Eur. J. Neurosci., 22, 2199 2206.
17. Flower, R.J., Harvey, E.A. Kingston, W.P. (1976) Inflammatory effects of prostaglandin D2 in rat and human skin. Br. J. Pharmacol., 56, 229 233.
18. Iadecola, C., Niwa, K., Nogawa, S., Zhao, X., Nagayama, M., Araki, E., Morham, S. Ross, M.E. (2001) Reduced susceptibility to ischemic brain injury and N-methyl-d-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl Acad. Sci. USA, 98, 1294 1299.
19. Kempski, O., Shohami, E., von Lubitz, D., Hallenbeck, J.M. Feuerstein, G. (1987) Postischemic production of eicosanoids in gerbil brain. Stroke, 18, 111 119.
20. Kitagawa, K., Matsumoto, M., Yang, G., Mabuchi, T., Yagita, Y., Hori, M. Yanagihara, T. (1998) Cerebral ischemia after bilateral carotid artery occlusion and intraluminal suture occlusion in mice: evaluation of the patency of the posterior communicating artery. J. Cereb. Blood Flow Metab., 18, 570 579.
21. Koch, K.A., Wessale, J.L., Moreland, R., Reinhart, G.A. Cox, B.F. (2005) Effects of BW245C, a prostaglandin DP receptor agonist, on systemic and regional haemodynamics in the anaesthetized rat. Clin. Exp. Pharmacol. Physiol., 32, 931 935.
22. Kontos, H.A., Wei, E.P., Ellis, E.F., Dietrich, W.D. Povlishock, J.T. (1981) Prostaglandins in physiological and in certain pathological responses of the cerebral circulation. Fed. Proc., 40, 2326 2330.
23. Li, X., Blizzard, K.K., Zeng, Z., DeVries, A.C., Hurn, P.D. McCullough, L.D. (2004) Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp. Neurol., 187, 94 104.
24. Liang, X., Wu, L., Hand, T. Andreasson, K. (2005) Prostaglandin D2 mediates neuronal protection via the DP1 receptor. J. Neurochem., 92, 477 486.
25. Littlejohns, L. Bader, M.K. (2005) Prevention of secondary brain injury: targeting technology. AACN Clin. Issues, 16, 501 514.
26. Liu, F., Gonzalo, J.A., Manning, S., O'Connell, L.E., Fedyk, E.R., Burke, K.E., Elder, A.M., Pulido, J.C., Cao, W., Tayber, O., Qiu, Y., Ghosh, S., Ocain, T.D., Hodge, M.R. Suzuki-Yagawa, Y. (2005) Pharmacological characterization of guinea pig chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). Prostaglandins Other Lipid Mediat., 76, 133 147.
27. Malki, S., Nef, S., Notarnicola, C., Thevenet, L., Gasca, S., Mejean, C., Berta, P., Poulat, F. Boizet-Bonhoure, B. (2005) Prostaglandin D2 induces nuclear import of the sex-determining factor SOX9 via its cAMP-PKA phosphorylation. EMBO J., 24, 1798 1809.
28. Masuda, Y., Ochi, Y., Karasawa, T., Hatano, N., Kadokawa, T. Shimizu, M. (1986) Protective effect of prostaglandins D2, E1 and I2 against cerebral hypoxia/anoxia in mice. Naunyn Schmiedebergs Arch. Pharmacol., 334, 282 289.
29. Matsuoka, T., Hirata, M., Tanaka, H., Takahashi, Y., Murata, T., Kabashima, K., Sugimoto, Y., Kobayashi, T., Ushikubi, F., Aze, Y., Eguchi, N., Urade, Y., Yoshida, N., Kimura, K., Mizoguchi, A., Honda, Y., Nagai, H. Narumiya, S. (2000) Prostaglandin D2 as a mediator of allergic asthma. Science, 287, 2013 2017.
30. Mizoguchi, A., Eguchi, N., Kimura, K., Kiyohara, Y., Qu, W.M., Huang, Z.L., Mochizuki, T., Lazarus, M., Kobayashi, T., Kaneko, T., Narumiya, S., Urade, Y. Hayaishi, O. (2001) Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. Proc. Natl Acad. Sci. USA, 98, 11674 11679.
31. Monneret, G., Cossette, C., Gravel, S., Rokach, J. Powell, W.S. (2003) 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils. J. Pharmacol. Exp. Ther., 304, 349 355.
32. Narumiya, S., Ogorochi, T., Nakao, K. Hayaishi, O. (1982) Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci., 31, 2093 2103.
33. Oida, H., Hirata, M., Sugimoto, Y., Ushikubi, F., Ohishi, H., Mizuno, N., Ichikawa, A. Narumiya, S. (1997) Expression of messenger RNA for the prostaglandin D receptor in the leptomeninges of the mouse brain. FEBS Lett., 417, 53 56.
34. Prandini, M.N., Neves Filho, A., Lapa, A.J. Stavale, J.N. (2005) Mild hypothermia reduces polymorphonuclear leukocytes infiltration in induced brain inflammation. Arq. Neuropsiquiatr., 63, 779 784.
35. Sharif, N.A., Williams, G.W. Davis, T.L. (2000) Pharmacology and autoradiography of human DP prostanoid receptors using [(3)H]-BWA868C, a DP receptor-selective antagonist radioligand. Br. J. Pharmacol., 131, 1025 1038.
36. Shichijo, M., Sugimoto, H., Nagao, K., Inbe, H., Encinas, J.A., Takeshita, K., Bacon, K.B. Gantner, F. (2003) Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto- prostaglandin D2-induced eosinophilia in rats. J. Pharmacol. Exp. Ther., 307, 518 525.
37. Spatz, M., Stanimirovic, D.B., Uematsu, S. McCarron, R.M. (1994) Vasoactive peptides and prostaglandin D2 in human cerebromicrovascular endothelium. J. Auton. Nerv. Syst., 49 (Suppl. S123 S127.
38. Spik, I., Brenuchon, C., Angeli, V., Staumont, D., Fleury, S., Capron, M., Trottein, F. Dombrowicz, D. (2005) Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J. Immunol., 174, 3703 3708.
39. Taniguchi, T., Morikawa, E., Mori, T. Matsui, T. (2005) Neuroprotective efficacy of selective brain hypothermia induced by a novel external cooling device on permanent cerebral ischemia in rats. Neurol. Res., 27, 613 619.
40. Ueno, R., Narumiya, S., Ogorochi, T., Nakayama, T., Ishikawa, Y. Hayaishi, O. (1982) Role of prostaglandin D2 in the hypothermia of rats caused by bacterial lipopolysaccharide. Proc. Natl Acad. Sci. USA, 79, 6093 6097.
41. Urade, Y. Eguchi, N. (2002) Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediat., 68-69, 375 382.
42. Whittle, B.J., Moncada, S., Mullane, K. Vane, J.R. (1983) Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue. Prostaglandins, 25, 205 223.
43. Wright, D.H., Nantel, F., Metters, K.M. Ford-Hutchinson, A.W. (1999) A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor. Eur. J. Pharmacol., 377, 101 115.
44. Zhuang, H., Pin, S., Li, X. Doré, S. (2003) Regulation of heme oxygenase expression by cyclopentenone prostaglandins. Exp. Biol. Med., 228, 499 505.